Below are the financial statements of Blueprint Medicines, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Product revenue, net | 478.95a | 204.21a | 110.99a |
| Collaboration, license and other revenue | 29.87a | 45.17a | 65.54a |
| License revenue - related party | 0a | 0a | 27.5a |
| Total revenues | 508.82a | 249.38a | 204.04a |
| Cost and operating expenses | — | — | — |
| Cost of sales | -20.16a | -8.54a | -17.81a |
| Collaboration loss sharing | 0a | -4.26a | -8.95a |
| Research and development | -341.43a | -427.72a | -477.42a |
| Selling, general and administrative | -359.27a | -295.14a | -237.37a |
| Total cost and operating expenses | -720.87a | -735.66a | -741.55a |
| Other income (expense) | — | — | — |
| Interest expense, net | -28.15a | -18.79a | -16.77a |
| Other income (expense), net | 0.66a | -0.95a | 2a |
| Debt extinguishment gain | 173.68a | 0a | 0a |
| Total other income (expense) | 146.18a | -19.74a | -14.76a |
| Loss before income taxes | -65.86a | -506.02a | -552.28a |
| Income tax expense | -1.23a | -0.97a | -5.24a |
| Net loss | -67.09a | -506.98a | -557.52a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Blueprint Medicines’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.